Literature DB >> 2892553

Human platelet beta 2-adrenoceptors: agonist-induced internalisation and down-regulation in intact cells.

N Cook1, S R Nahorski, D B Barnett.   

Abstract

1. The effect of isoprenaline (10 microM at 37 degrees C for 30 min) pretreatment on [125I]-(-)-pindolol ([125I]-(-)-Pin) binding to beta 2-adrenoceptors on intact human platelets has been examined. 2. By use of saturation analysis, maximal binding capacity (Bmax) of [125I]-(-)-Pin binding in control and treated cells was assessed in the presence of 1 microM (-)-propranolol or 1 microM (+/-)-CGP 12177 which were taken to represent total or cell surface beta-adrenoceptors respectively. Assay incubations were performed at 37 degrees C and 4 degrees C, the latter to prevent recycling of internalised receptors. 3. Isoprenaline treatment resulted in an identical, highly significant, loss of binding sites (approximately equal to 25%) defined by (-)-propranolol at both assay temperatures as compared to control cells. Binding sites identified in the presence of (+/-)-CGP 12177 were reduced to a much greater extent (approximately equal to 70%), but this was only seen when assays were performed at 4 degrees C. 4. Agonist-induced changes in receptor numbers were concentration-dependent with half maximal receptor loss occurring at an isoprenaline concentration of approximately 2 x 10(-8) M. These effects were inhibited by the presence of a beta-adrenoceptor antagonist and absent if agonist pretreatment was performed at 4 degrees C. 5. Recovery experiments showed that the isoprenaline-induced reduction in total receptor number defined by (-)-propranolol was irreversible whereas the reduction in cell surface receptors defined by (+/-)-CGP 12177 was rapidly reversible (less than 40 min). 6. These data suggest that isoprenaline treatment of intact human platelets causes redistribution of beta 2-adrenoceptors. A proportion are sequestered away from the cell surface (internalised), becoming inaccessible to the hydrophilic ligand (+/-)-CGP 12177. A smaller proportion defined by (-)-propranolol are apparently totally lost from the cell (down regulated).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892553      PMCID: PMC1853697          DOI: 10.1111/j.1476-5381.1987.tb11360.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies.

Authors:  E L Rugg; D B Barnett; S R Nahorski
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

3.  Atypical characteristics of frog and chick erythrocyte beta-adrenoceptors.

Authors:  K E Dickinson; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1981-08-27       Impact factor: 4.432

4.  Internalization of beta-adrenergic receptor binding sites: involvements of lysosomal enzymes.

Authors:  D M Chuang
Journal:  Biochem Biophys Res Commun       Date:  1982-04-29       Impact factor: 3.575

5.  Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.

Authors:  A M Siegl; J W Daly; J B Smith
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process.

Authors:  Y F Su; T K Harden; J P Perkins
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

8.  (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.

Authors:  K Barovsky; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1980

9.  Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells.

Authors:  D A Green; J Friedman; R B Clark
Journal:  J Cyclic Nucleotide Res       Date:  1981

10.  Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells.

Authors:  M Shear; P A Insel; K L Melmon; P Coffino
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

View more
  3 in total

1.  Localization of beta-adrenergic receptors in A431 cells in situ. Effect of chronic exposure to agonist.

Authors:  H Y Wang; M Berrios; C C Malbon
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  Beta-adrenoceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states.

Authors:  G D Dimitriadis; S J Richards; M Parry-Billings; B Leighton; E A Newsholme; R A Challiss
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

3.  Is the human platelet beta 2 adrenoceptor coupled to adenylate cyclase?

Authors:  N Cook; S R Nahorski; C Jagger; D B Barnett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.